Last week, Saving Lives at Birth: A Grand Challenge for Development announced $3.4 million in new funding to help develop and refine 12 of the world's most promising ideas to save lives at birth. Launched in 2011, The Saving Lives at Birth partnership is a global call for groundbreaking, scalable solutions to infant and maternal mortality around the time of birth. Saving Lives at Birth aims to address the 303,000 maternal deaths, 2.7 million neonatal deaths, and 2.6 million stillbirths that occur each year around the world. To date, Saving Lives at Birth innovations have benefited more than 1.5 million women and newborns and saved nearly 10,000 lives.
From a microneedle patch to deliver the antibiotics of amoxicillin and gentamicin for treatment of newborn sepsis to low-cost, easy-to-use, electricity-free infusion pump that provides safe and accurate delivery of lifesaving medications, fluids, and nutrition in newborn and obstetric emergencies, Saving Lives at Birth: A Grand Challenge for Development will invest more than $3.4 additional million in groundbreaking solutions to protect mothers and newborns during their most vulnerable hours — during and immediately after delivery. The 12 award nominees were selected from nearly 650 submissions, with more than half of the applications coming from low- and middle-income countries. They are now part of a growing community of more than 93 innovators supported by the Saving Lives at Birthpartnership.
- Learn more about Saving Lives at Birth: A Grand Challenge for Development.
- Read the press release announcing this year's finalists.